Rapid COVID and flu tests put to the test in real clinics

NCT ID NCT05728970

Completed Diagnosis Sponsor: LumiraDx UK Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checked how accurate two rapid tests (LumiraDx SARS-CoV-2 Ag Ultra and LumiraDx SARS-CoV-2 & Flu A/B) are at detecting COVID-19 and flu in people with symptoms. 716 participants provided nasal swabs at clinics. The results were compared to standard lab tests to measure sensitivity and specificity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19 Infections influenza lung disorder swine influenza

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 INFLUENZA A INFLUENZA B SARS-COV-2

Contacts and locations

Locations

Alliance for Multispecialty Research, LLC

Layton, Utah, 84041, United States
Barrett Clinic

La Vista, Nebraska, 68128, United States
Hillcrest Medical Research

DeLand, Florida, 32720, United States
Hillcrest Medical Research, LLC

DeLand, Florida, 32720, United States
Marisela Gonzalez MD PA

Miami, Florida, 33155, United States
Mercy Family Clinic

Dallas, Texas, 75211, United States
Meridian Clinical Research

Lincoln, Nebraska, 68510, United States
Meridian Clinical Research, LLC. / Velocity Clinical Research

Hampton, Virginia, 23666, United States
Paragon Rx Clinical, Inc

Garden Grove, California, 92840, United States
Torrance Clinical Research Institute Inc.

Lomita, California, 90717, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.